Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Corey

Showing results (181-190 of 511) with videos related to

Pageof 52
Sort By:
Annals of Internal Medicine|June 1, 1989
Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infectionA Langenberg, J Benedetti, J Jenkins, et al.
Progress in Clinical and Biological Research|January 1, 1987
Pancreatic and intestinal dysfunction in cystic fibrosisG G Forstner, H R Kopelman, P R Durie, et al.
American Journal of Obstetrics and Gynecology|May 1, 1982
Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrencesL A Vontver, D E Hickok, Z Brown, et al.
The Journal of Infectious Diseases|October 1, 1991
Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reactionR W Cone, A C Hobson, J Palmer, et al.
Journal of Virology|December 1, 1988
Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccineJ M Zarling, P A Moran, L Brewer, et al.
BMJ (Clinical Research Ed.)|November 19, 1994
Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populationsF M Cowan, A M Johnson, R Ashley, et al.
AIDS Research and Human Retroviruses|May 1, 1994
HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipientsM J McElrath, M Hoffman, S Kluckling, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infectionsA Wald, J Benedetti, G Davis, et al.
The New England Journal of Medicine|June 4, 1987
Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral typeW E Lafferty, R W Coombs, J Benedetti, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 1990
Characterization of oligosaccharide chains on mouse mammary tumor virus envelope proteins and the implications for the mechanism of their glucocorticoid regulated processingL D Snider, J L Corey, S K Rabindran, et al.
Pageof 52

Showing results (181-190 of 511) with videos related to

Sort By:
Pageof 52
Annals of Internal Medicine|June 1, 1989
Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infectionA Langenberg, J Benedetti, J Jenkins, et al.
Progress in Clinical and Biological Research|January 1, 1987
Pancreatic and intestinal dysfunction in cystic fibrosisG G Forstner, H R Kopelman, P R Durie, et al.
American Journal of Obstetrics and Gynecology|May 1, 1982
Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrencesL A Vontver, D E Hickok, Z Brown, et al.
The Journal of Infectious Diseases|October 1, 1991
Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reactionR W Cone, A C Hobson, J Palmer, et al.
Journal of Virology|December 1, 1988
Herpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccineJ M Zarling, P A Moran, L Brewer, et al.
BMJ (Clinical Research Ed.)|November 19, 1994
Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populationsF M Cowan, A M Johnson, R Ashley, et al.
AIDS Research and Human Retroviruses|May 1, 1994
HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipientsM J McElrath, M Hoffman, S Kluckling, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infectionsA Wald, J Benedetti, G Davis, et al.
The New England Journal of Medicine|June 4, 1987
Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral typeW E Lafferty, R W Coombs, J Benedetti, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 1990
Characterization of oligosaccharide chains on mouse mammary tumor virus envelope proteins and the implications for the mechanism of their glucocorticoid regulated processingL D Snider, J L Corey, S K Rabindran, et al.
Pageof 52